USFDA concludes inspection at Shilpa Medicare’s API sites in Karnataka

10 Feb 2020 Evaluate

US Food and Drug Administration (USFDA) has concluded inspection at Shilpa Medicare’s Active Pharmaceutical Ingredients (API) sites (Unit I and Unit II) which are located at Raichur District, Karnataka between February 3, 2020 and February 7, 2020. The inspection concluded with 'ZERO' observations.

Shilpa Medicare produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.

Shilpa Medicare Share Price

331.30 -2.65 (-0.79%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×